Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands

Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model

Published:2011-10-11 Issue:10 Volume:6 Page:e26139
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Adarkwah Charles Christian,Gandjour Afschin,Akkerman Maren,Evers Silvia M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

2. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.;AH Mokdad;JAMA,2003

3. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.;E Ritz;Am J Kidney Dis,1999

4. Epidemiologie and Verlauf des Diabetes mellitus in Deutschland,;G Giani,2004

5. The development of the renal replacement program in the Netherlands in the period 1990-2006.[Article in Dutch] Registry renal replacement Netherland.,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study;Health Technology Assessment;2024-07

2. The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period;International Journal of Cardiology;2023-01

3. Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts;Diabetes Therapy;2022-03-15

4. Outreach and Connection to Care for Chronic Kidney Disease in a Workplace Wellness Setting: A Cost-Effectiveness Analysis;Population Health Management;2020-12-01

5. On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers;Frontiers in Public Health;2020-10-30